Abstract
The method outlined here enables evaluation of the neutralization potency of monoclonal and polyclonal antibodies against in vitro cultured hepatitis C virus (HCV). The high variation in envelope protein sequence among HCV isolates necessitates the inclusion of several isolates, spanning the major genotypes of HCV, in order to make strong conclusions concerning the cross-reactive neutralization potential of a given antibody. This would be particularly relevant for any neutralization experiments aimed at uncovering novel therapeutic- or vaccine-relevant antibodies. In addition, these assays can also be used to compare neutralization sensitivity of novel cultured HCV to that of previously characterized isolates.
| Original language | English |
|---|---|
| Journal | Methods in molecular biology |
| Volume | 1911 |
| Pages (from-to) | 433-439 |
| Number of pages | 7 |
| ISSN | 1064-3745 |
| DOIs | |
| Publication status | Published - 2019 |
Keywords
- Antibodies
- HCV
- Hepatitis C virus
- Immunostaining
- Neutralization
- Vaccine
Fingerprint
Dive into the research topics of 'In Vitro Neutralization Assay Using Cultured Hepatitis C Virus'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS